T839M (p.Thr839Met) variant of GUCY2D (Retinal guanylyl cyclase 1)
T839M (p.Thr839Met) in GUCY2D (Retinal guanylyl cyclase 1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Cone-rod dystrophy 6. The available variant effect predictions contribute to a CATVariant prioritization score of 0.82 / 1. The record also includes population frequency data, published literature, and structural context.
T839M (p.Thr839Met) variant details
- p.Thr839Met
- rs61750174
- ClinGen CA226087
- ClinVar RCV000009950
- ClinVar RCV000084864
- Pathogenic
- Cone-rod dystrophy 6
- Missense
- Variant Prioritization Score for Impact Estimate 0.817
- REVEL 0.80
- ESM-1b 1.00
- AlphaMissense 0.83
- CADD 26.30
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Pathogenic (Cone-rod dystrophy 6)
- EBI: Pathogenic
- UniProt: Pathogenic
- Most common in the African/African-American population (allele frequency 2.5e-05)
- Structural context available
- Cited in: Spectrum of retGC1 mutations in Leber's congenital amaurosis. (PMID 10951519)
- Cited in: Nonsyndromic Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy Overview. (PMID 30285347)